Health and Fitness Health and Fitness
Mon, November 28, 2011
[ Mon, Nov 28th 2011 ] - Market Wire
Brookwater Files Fiscal Year-End Financials and A .. Wagner Freire to the Forbes &;; Manhat
[ Mon, Nov 28th 2011 ] - Market Wire
Celsion Announces Unanimous Recommendation by Ind .. ittee to Continue and Complete Phase III HEAT Stu
[ Mon, Nov 28th 2011 ] - Market Wire
ARIAD to Present at the 2011 Deutsche Bank BioFEST
[ Mon, Nov 28th 2011 ] - Market Wire
Micromet Initiates Global Phase 2 Trial of Blinat .. Relapsed/Refractory Acute Lymphoblastic Leukemia
[ Mon, Nov 28th 2011 ] - Market Wire
POZEN Monetizes Its Treximet Royalty Stream for $75 Million
[ Mon, Nov 28th 2011 ] - Market Wire
FDA Grants IND to Investigator at Baylor College .. r Phase 2A Trial with AEZS-130 in Cancer Cachexia
[ Mon, Nov 28th 2011 ] - Market Wire
Catheterization and Cardiovascular Interventions Journal Publishes Results from USpella Registry
[ Mon, Nov 28th 2011 ] - Market Wire
Life Technologies Makes Fluorescence Microscopy Accessible to All Scientists
[ Mon, Nov 28th 2011 ] - Market Wire
US Patent Office Rejects All 191 Claims in Key Mo .. oSol Patent Asserted Against BioDelivery Sciences
[ Mon, Nov 28th 2011 ] - Market Wire
ArthroCare Announces Agreement in Principle to Settle Securities Class Action
[ Mon, Nov 28th 2011 ] - Market Wire
OncoSec to Present at 15th Annual Biotech and Specialty Pharmaceuticals Conference
[ Mon, Nov 28th 2011 ] - Market Wire
Exelixis Signs CRADA With National Cancer Institute to Expand Development Plan of Cabozantinib
[ Mon, Nov 28th 2011 ] - Market Wire
ShangPharma to Attend Two Upcoming Investor Conferences
Sun, November 27, 2011
[ Sun, Nov 27th 2011 ] - Market Wire
Regeneron and Bayer Initiate Phase 3 Clinical Pro .. of Wet Age-Related Macular Degeneration in China
[ Sun, Nov 27th 2011 ] - Market Wire
Hologic Introduces Synthesized 2D Image Algorithm .. ed for a 2D Mammogram in a 2D plus 3D Tomosynthes
Fri, November 25, 2011
[ Fri, Nov 25th 2011 ] - Market Wire
Cytokinetics Files Replacement Shelf Registration Statement
[ Fri, Nov 25th 2011 ] - Market Wire
Mindray to Hold Annual General Meeting in Hong Kong on December 19, 2011
[ Fri, Nov 25th 2011 ] - Market Wire
PharmaGap Liposomal Formulations Achieve Key Milestones for Clinical Trials
[ Fri, Nov 25th 2011 ] - Market Wire
Celgene Corporation to Present at the Piper Jaffray Health Care Conference 2011
Thu, November 24, 2011
[ Thu, Nov 24th 2011 ] - Market Wire
RepliCel Class C Shareholders Convert Into Common Shares
[ Thu, Nov 24th 2011 ] - Market Wire
Theratechnologies Wins ADRIQ's 2011 Product Innovation Award
Wed, November 23, 2011
[ Wed, Nov 23rd 2011 ] - Market Wire
Imaging Diagnostic vende el sistema CTLM a Mxico, el primero de cinco sistemas que se instalarn
[ Wed, Nov 23rd 2011 ] - Market Wire
NuVasive to Participate in the Piper Jaffray Health Care Conference
[ Wed, Nov 23rd 2011 ] - Market Wire
Amylin Pharmaceuticals to Present at the 23rd Annual Piper Jaffray Healthcare Conference
[ Wed, Nov 23rd 2011 ] - Market Wire
Cynapsus Announces Parkinson's Drug Candidate Progress and Upcoming Milestones
[ Wed, Nov 23rd 2011 ] - Market Wire
Alere Acquires Arriva Medical
[ Wed, Nov 23rd 2011 ] - Market Wire
Imaging Diagnostic Sells CTLM System to Mexico;; First of Five Systems to Be Installed
[ Wed, Nov 23rd 2011 ] - Market Wire
Transcept Pharmaceuticals Announces FDA Approval .. ate sublingual tablet) C-IV For Use as Needed for
[ Wed, Nov 23rd 2011 ] - Market Wire
Transcept Pharmaceuticals to Host Conference Call to Discuss FDA Approval of Intermezzo
[ Wed, Nov 23rd 2011 ] - Market Wire
Neurocrine Biosciences to Present at the 23rd Annual Piper Jaffray Health Care Conference

Neurocrine Biosciences to Present at the 23rd Annual Piper Jaffray Health Care Conference


Published on 2011-11-23 10:10:58 - Market Wire
  Print publication without navigation


Neurocrine Biosciences to Present at the 23rd Annual Piper Jaffray Health Care... -- SAN DIEGO, Nov. 23, 2011 /PRNewswire/ --

Neurocrine Biosciences to Present at the 23rd Annual Piper Jaffray Health Care Conference

[ ]

Live Audio Webcast Wednesday, November 30, 2011

  

SAN DIEGO, Nov. 23, 2011 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: [ NBIX ]) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the 23rd Annual Piper Jaffray Health Care Conference in New York.   

The live presentation takes place on Wednesday, November 30, 2011 at 11:00 a.m. Eastern Time / 8:00 a.m. Pacific Time.  The presentation will be webcast and may be accessed on the Company's website at [ http://www.neurocrine.com ].

If you are unable to attend the webcast and would like further information on this announcement please contact Investor Relations at Neurocrine Biosciences at (858) 617-7600.  Viewers are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software.  A replay of the presentation will be available approximately one hour after the conclusion of the live event and will be archived on the website for two weeks.

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world, including endometriosis, stress-related disorders, tardive dyskinesia, uterine fibroids, pain, diabetes, insomnia, and other neurological and endocrine-related diseases and disorders. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at [ http://www.neurocrine.com ].

SOURCE Neurocrine Biosciences, Inc.

[ Back to top ]

RELATED LINKS
[ http://www.neurocrine.com ]

Contributing Sources